Canada has about 337 MW of AI data-centre capacity, and there are more than 20 GW in projects that are ‘under planning or ...
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (Acumen), a clinical-stage biopharmaceutical company developing novel therapeutics that target soluble amyloid beta oligomers (AβOs) for the ...
Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative ...
Nvidia CEO Jensen Huang on Tuesday kicked off the AI chipmaker's GTC 2025 conference with a presentation highlighting the ...